Application 022027
- Type
- NDA
- Sponsor
- SCHERING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOXAFIL | POSACONAZOLE | SUSPENSION; ORAL | 40MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| posaconazole | POSACONAZOLE | Mylan Institutional LLC | 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | 2026-07-15 | Warnings, Adverse reactions | POSACONAZOLE |
| posaconazole | POSACONAZOLE | Gland Pharma Limited | 52d9d29e-4a37-4926-aa57-8477f5447b34 | 2026-06-09 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Major Pharmaceuticals | 8e1e69b8-cf41-47cc-a3ec-1baee55f099a | 2026-06-01 | Warnings, Adverse reactions | POSACONAZOLE |
| posaconazole | POSACONAZOLE | Hikma Pharmaceuticals USA Inc. | 282ddea7-47d8-44e4-8806-169d7cafa951 | 2026-05-18 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Lupin Pharmaceuticals, Inc. | 548124ce-8050-46a9-967b-ff23dfb18633 | 2026-05-07 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | ATLANTIC BIOLOGICALS CORP. | dfbc636f-d8a7-4232-a6b0-cda49caadc9b | 2026-04-20 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Amneal Pharmaceuticals NY LLC | 5f795eca-7a03-4c91-9a0e-c1235791b665 | 2026-03-20 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | ENDO USA, Inc. | e031b632-8e57-4359-87bd-a5da02bdc55f | 2026-02-18 | Warnings, Adverse reactions | POSACONAZOLE |
| NOXAFIL | POSACONAZOLE | Merck Sharp & Dohme LLC | b073b082-7b57-4423-8c06-4fd4263d6f84 | 2026-02-13 | Warnings, Adverse reactions | NOXAFIL POSACONAZOLE |
| posaconazole | POSACONAZOLE | GLENMARK PHARMACEUTICALS INC., USA | a2ba0343-cd17-4b23-8356-005a1dfd0b35 | 2026-02-11 | Warnings, Adverse reactions | POSACONAZOLE |
| posaconazole | POSACONAZOLE | GLENMARK PHARMACEUTICALS INC., USA | 91f89a3b-2479-4d05-9997-7b0cfaa496ec | 2026-02-11 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Dr.Reddys Laboratories Inc | d8d8dd03-46b5-bd26-bb27-7ca31d8c3326 | 2026-01-25 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Par Health USA, LLC | 4032672e-1bb0-427d-a3b3-09cda4beaf34 | 2026-01-20 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | AvKARE | f9c81d88-8e2c-fa53-e053-6394a90ac5c4 | 2026-01-19 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | American Health Packaging | e809a31a-09da-46bf-bcaa-f34b7f3b54a3 | 2025-11-17 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Bryant Ranch Prepack | f15fc7d4-04ea-4be5-bfed-9a8bae74591c | 2025-11-11 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | Bryant Ranch Prepack | 42a53b61-be3b-4c69-a3df-d12401dbd0e4 | 2025-06-26 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Eugia US LLC | 2e88e379-b712-4dec-97a2-c90ef3638372 | 2025-06-07 | Warnings, Adverse reactions | POSACONAZOLE |
| Posaconazole | POSACONAZOLE | A2A Integrated Pharmaceuticals | 4d14ceab-196e-4dc3-8b21-5c4629ada161 | 2025-02-28 | Warnings, Adverse reactions | POSACONAZOLE |
| POSACONAZOLE | POSACONAZOLE | Golden State Medical Supply, Inc. | e883b495-d7e7-6d58-e053-2a95a90a1cd3 | 2025-02-24 | Warnings, Adverse reactions | POSACONAZOLE |